Keynote: Designing, Formulating, and Manufacturing Molecules for Long-Acting Therapies

Tuesday, November 11, 2025

1:30 PM - 2:30 PM CT

Location:302 ABC

Manufacturing and Analytical Characterization

Keynote Speaker(s)

William Rowe, BS, PhD (he/him/his)

Senior Director
Gilead Sciences
San Bruno, California

Moderator(s)

Pallavi Pawar, PhD (she/her/hers)

Principal Research Scientist II (Associate Director)
Gilead Sciences
Foster City

Long-acting therapies can offer additional treatment options and quality of life for the patients we serve. Developing a long-acting therapy starts with the design of the molecule, in partnership with prototype formulations, to meet the unique requirements of these dosage forms. This presentation will use case studies to share challenges and creative solutions that result from an integrated effort throughout the discovery and development process.

Learning Objectives:

Upon completion, participants will be able to understand the unique challenges encountered during development of long-acting therapies.
Upon completion, participants will be able to gain insights into how numerous functions within Discovery and Development need to collaborate to successfully develop long-acting therapies.
Upon completion, participants will be excited to take on the scientific challenges and expand the industry's ability to develop long-acting therapies.